c4d antibody

C4d Antibody

DF13993 100ul
EUR 420

C4d Antibody

DF13993-100ul 100ul
EUR 280

C4d Antibody

DF13993-200ul 200ul
EUR 350

C4d, Antibody

GWB-642521 1 ml Ask for price

C4d, Antibody

GWB-E746F7 7 ml Ask for price

C4d Antibody

GWB-822CB1 0.1 mg Ask for price

C4d Antibody (Neoantigen)

GWB-38EC16 0.1 mg Ask for price

Anti-Human C4d antibody

STJ16101318 1 mL
EUR 1138.8

Anti-Human C4d antibody

STJ16101454 1 mL
EUR 1138.8

Complement C4d(C4D204) Antibody

BNCH0204-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D204), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNCH0204-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D204), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNCH0205-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D205), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNCH0205-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D205), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNC700204-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D204), CF770 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNC700204-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D204), CF770 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNC700205-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D205), CF770 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNC700205-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D205), CF770 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNC800204-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D204), CF680 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNC800204-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D204), CF680 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNC800205-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D205), CF680 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNC800205-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D205), CF680 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNC810204-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D204), CF680R conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNC810204-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D204), CF680R conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNC810205-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D205), CF680R conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNC810205-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D205), CF680R conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNC550204-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D204), CF555 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNC550204-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D204), CF555 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNC550205-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D205), CF555 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNC550205-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D205), CF555 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNC430204-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D204), CF543 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNC430204-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D204), CF543 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNC430205-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D205), CF543 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNC430205-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D205), CF543 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNC610204-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D204), CF660R conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNC610204-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D204), CF660R conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNC610205-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D205), CF660R conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNC610205-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D205), CF660R conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNC050204-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D204), CF405M conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNC050204-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D204), CF405M conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNC050205-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D205), CF405M conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNC050205-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D205), CF405M conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNCA0204-250 250uL
EUR 459.6
Description: Primary antibody against Complement C4d(C4D204), APC conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNCA0205-250 250uL
EUR 459.6
Description: Primary antibody against Complement C4d(C4D205), APC conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNCAP0204-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D204), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNCAP0204-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D204), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNCAP0205-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4D205), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNCAP0205-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4D205), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNCP0204-250 250uL
EUR 459.6
Description: Primary antibody against Complement C4d(C4D204), PerCP conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNCP0205-250 250uL
EUR 459.6
Description: Primary antibody against Complement C4d(C4D205), PerCP conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D204) Antibody

BNCR0204-250 250uL
EUR 459.6
Description: Primary antibody against Complement C4d(C4D204), RPE conjugate, Concentration: 0.1mg/mL

Complement C4d(C4D205) Antibody

BNCR0205-250 250uL
EUR 459.6
Description: Primary antibody against Complement C4d(C4D205), RPE conjugate, Concentration: 0.1mg/mL

OASA11515-100UG - C4d Antibody

OASA11515-100UG 0.1mg
EUR 309

C4d / Complement 4d Antibody

V9091-100UG 100 ug
EUR 424.15
Description: This mAb is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound C4d. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of Abs to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product Complement 4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival. Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

C4d / Complement 4d Antibody

V9091-20UG 20 ug
EUR 186.15
Description: This mAb is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound C4d. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of Abs to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product Complement 4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival. Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

C4d / Complement 4d Antibody

V9091IHC-7ML 7 ml
EUR 424.15
Description: This mAb is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound C4d. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of Abs to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product Complement 4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival. Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

C4d / Complement 4d Antibody

V9091SAF-100UG 100 ug
EUR 424.15
Description: This mAb is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound C4d. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of Abs to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product Complement 4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival. Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

C4d / Complement 4d Antibody

V7025-100UG 100 ug
EUR 424.15
Description: This antibody is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound protein. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of antibodies to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product C4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. C4d has been shown to be a significant predictor of transplant kidney graft survival. C4d antibody, combined with antibody to C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

C4d / Complement 4d Antibody

V7025-20UG 20 ug
EUR 186.15
Description: This antibody is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound protein. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of antibodies to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product C4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. C4d has been shown to be a significant predictor of transplant kidney graft survival. C4d antibody, combined with antibody to C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

C4d / Complement 4d Antibody

V7025SAF-100UG 100 ug
EUR 424.15
Description: This antibody is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound protein. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of antibodies to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product C4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. C4d has been shown to be a significant predictor of transplant kidney graft survival. C4d antibody, combined with antibody to C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

C4d / Complement 4d Antibody

V2021-100UG 100 ug
EUR 424.15
Description: This antibody is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound protein. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of antibodies to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product C4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. C4d has been shown to be a significant predictor of transplant kidney graft survival. C4d antibody, combined with antibody to C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

C4d / Complement 4d Antibody

V2021-20UG 20 ug
EUR 186.15
Description: This antibody is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound protein. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of antibodies to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product C4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. C4d has been shown to be a significant predictor of transplant kidney graft survival. C4d antibody, combined with antibody to C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

C4d / Complement 4d Antibody

V2021CF488-100T 100 Tests
EUR 424.15
Description: This antibody is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound protein. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of antibodies to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product C4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. C4d has been shown to be a significant predictor of transplant kidney graft survival. C4d antibody, combined with antibody to C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

C4d / Complement 4d Antibody

V2021IHC-7ML 7 ml
EUR 424.15
Description: This antibody is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound protein. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of antibodies to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product C4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. C4d has been shown to be a significant predictor of transplant kidney graft survival. C4d antibody, combined with antibody to C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

C4d / Complement 4d Antibody

V2021SAF-100UG 100 ug
EUR 424.15
Description: This antibody is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound protein. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of antibodies to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product C4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. C4d has been shown to be a significant predictor of transplant kidney graft survival. C4d antibody, combined with antibody to C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

Complement C4d(C4203) Antibody

BNCH0203-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4203), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Complement C4d(C4203) Antibody

BNCH0203-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4203), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Complement C4d(TDM16) Antibody

BNCAP1232-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(TDM16), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Complement C4d(TDM16) Antibody

BNCAP1232-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(TDM16), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Complement C4d(TDM16) Antibody

BNCH1232-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(TDM16), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Complement C4d(TDM16) Antibody

BNCH1232-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(TDM16), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Complement C4d(C4203) Antibody

BNC700203-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4203), CF770 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4203) Antibody

BNC700203-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4203), CF770 conjugate, Concentration: 0.1mg/mL

Complement C4d(TDM16) Antibody

BNC701232-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(TDM16), CF770 conjugate, Concentration: 0.1mg/mL

Complement C4d(TDM16) Antibody

BNC701232-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(TDM16), CF770 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4203) Antibody

BNC800203-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4203), CF680 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4203) Antibody

BNC800203-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4203), CF680 conjugate, Concentration: 0.1mg/mL

Complement C4d(TDM16) Antibody

BNC801232-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(TDM16), CF680 conjugate, Concentration: 0.1mg/mL

Complement C4d(TDM16) Antibody

BNC801232-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(TDM16), CF680 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4203) Antibody

BNC810203-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4203), CF680R conjugate, Concentration: 0.1mg/mL

Complement C4d(C4203) Antibody

BNC810203-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4203), CF680R conjugate, Concentration: 0.1mg/mL

Complement C4d(TDM16) Antibody

BNC811232-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(TDM16), CF680R conjugate, Concentration: 0.1mg/mL

Complement C4d(TDM16) Antibody

BNC811232-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(TDM16), CF680R conjugate, Concentration: 0.1mg/mL

Complement C4d(C4203) Antibody

BNC550203-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4203), CF555 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4203) Antibody

BNC550203-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4203), CF555 conjugate, Concentration: 0.1mg/mL

Complement C4d(TDM16) Antibody

BNC551232-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(TDM16), CF555 conjugate, Concentration: 0.1mg/mL

Complement C4d(TDM16) Antibody

BNC551232-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(TDM16), CF555 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4203) Antibody

BNC430203-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(C4203), CF543 conjugate, Concentration: 0.1mg/mL

Complement C4d(C4203) Antibody

BNC430203-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(C4203), CF543 conjugate, Concentration: 0.1mg/mL

Complement C4d(TDM16) Antibody

BNC431232-100 100uL
EUR 238.8
Description: Primary antibody against Complement C4d(TDM16), CF543 conjugate, Concentration: 0.1mg/mL

Complement C4d(TDM16) Antibody

BNC431232-500 500uL
EUR 652.8
Description: Primary antibody against Complement C4d(TDM16), CF543 conjugate, Concentration: 0.1mg/mL

Back to top